Continuum Advisory »

Allogene Therapeutics shares owned by Continuum Advisory

Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by Continuum Advisory from 13F filings

Historical chart of Continuum Advisory investment in Allogene Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Allogene Therapeutics held by Continuum Advisory consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Allogene Therapeutics by Continuum Advisory

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.6k 550 2.86

More positions owned by Continuum Advisory

Capital Group Dividend Value Etf Etf (CGDV)
Apple Stock (AAPL)
Jpmorgan Core Plus Bond Etf Jpmorgan Core Plus Bond Fund Etf (JCPB)
Microsoft Corp Stock (MSFT)
Vanguard Extended Market Etf Etf (VXF)
Vanguard Total Stock Market Etf Etf (VTI)
Ishares 20 Year Treasury Bond Etf Etf (TLT)
Invesco Qqq Trust Series I Etf (QQQ)
Amazon Stock (AMZN)
Vanguard Total Bond Market Etf Etf (BND)
Barnes Group Stock (B)
Spdr Msci Usa Strategicfactors Etf Etf (QUS)
Vanguard Large-cap Etf Etf (VV)
Ishares S&p 100 Etf Etf (OEF)
Ishares Core S&p 500 Etf Etf (IVV)

View all positions for Continuum Advisory

Top funds holding Allogene Therapeutics

FMR
Tpg Gp A
BlackRock
Vanguard Group
PRIMECAP Management Company
Jpmorgan Chase & Co
T. Rowe Price Associates
Boxer Capital
Citadel Advisors
Frazier Life Sciences Management
Woodline Partners
Geode Capital Management
Morgan Stanley
Dimensional Fund Advisors
Two Sigma Investments

View all funds holding Allogene Therapeutics